Kenvue Inc.
KVUEConsumer DefensiveNASDAQHousehold & Personal Products · Last scanned Jun 1, 2026
Scan Results
Daily timeframeKenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. With a market capitalization of $33.31B, it sits in large-cap territory. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health.
Market Cap
$33.31B
Beta
0.52
P/E (TTM)
20.65
P/E (Fwd)
14.03
EPS (TTM)
$0.84
EPS (Fwd)
$1.24
ROE
15.7%
ROA
7.1%
Cash
$1.08B
Total Debt
$8.80B
Free CF
$1.86B
52W Change
-21.9%
Annual Financials
Cash vs Debt
Kenvue Inc. carries $8.80B in total debt against $1.08B in cash reserves — debt is roughly 8.2x the cash position. Managing this leverage effectively will be important for long-term financial stability. Annual free cash flow of $1.86B supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Return on equity stands at 15.7%, which is strong for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. An ROA of 7.1% suggests reasonable efficiency in deploying the company's asset base. Revenue has been relatively flat, moving from $14.95B (2022) to $15.12B (2025).
KVUE's low beta indicates it tends to be less volatile than the broader market, which may suit investors seeking more stable price behavior. Kenvue Inc. carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing KVUE.